Search results
26 paź 2021 · Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu syndrome, is a rare inherited disorder characterized by abnormal blood vessel formation in the skin, mucous membranes, and organs including the lungs, liver, and central nervous system.
As the name implies, HHT runs in families, caused by mutations in at least two specific genes. HHT is also known as Osler Weber Rendu syndrome. Mount Sinai experts lead the way in treating HHT. The condition affects everyone differently, but there are some commonalities.
1 lis 2021 · Also known as Osler-Weber-Rendu syndrome, HHT was named after 19th-century physicians William Osler, Fredrick Parker Weber, and Henri Jules Louis Marie Rendu , and the disease results in multisystemic vascular lesions, known as telangiectasias, and visceral arteriovenous malformations (AVMs).
If you are looking for the most advanced and specialized treatment for Hereditary Hemorrhagic Telangiectasia (HHT, Osler-Weber-Rendu Disease), we can help. At the Vascular Birthmark Institute of New York, we extend a wealth of experience and expertise when it comes to all vascular lesions.
Learn about Osler-Weber-Rendu syndrome, find a doctor, complications, outcomes, recovery and follow-up care for Osler-Weber-Rendu syndrome.
Yale New Haven Hospital Interventional Radiology treats Hereditary Hemorrhagic Telangiectasia (HHT), also known as Osler-Weber-Rend syndrome, a rare genetic condition characterized by abnormal blood vessel formation and resulting in telangiectasia and arteriovenous malformations (AVMs).
Hereditary hemorrhagic telangiectasia, or Osler-Weber-Rendu disease, was first recognized in 1896. It is an autosomal dominant disorder with variable penetrance characterized by epistaxis, mucocutaneous telangiectases, and visceral arteriovenous malformations.
